Denmark
· Delayed Price · Currency is DKK CPH:SMSMED Statistics
Total Valuation
CPH:SMSMED has a market cap or net worth of DKK 136.50 million. The enterprise value is 185.08 million.
| Market Cap | 136.50M |
| Enterprise Value | 185.08M |
Important Dates
The last earnings date was Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CPH:SMSMED has 27.69 million shares outstanding. The number of shares has increased by 0.57% in one year.
| Current Share Class | 27.69M |
| Shares Outstanding | 27.69M |
| Shares Change (YoY) | +0.57% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.16% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 48.28.
| PE Ratio | 48.28 |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| PB Ratio | 1.70 |
| P/TBV Ratio | 1.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 21.80 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.63, with an EV/FCF ratio of -9.63.
| EV / Earnings | 65.79 |
| EV / Sales | 0.75 |
| EV / EBITDA | 13.63 |
| EV / EBIT | 32.38 |
| EV / FCF | -9.63 |
Financial Position
The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.60.
| Current Ratio | 1.75 |
| Quick Ratio | 0.44 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 3.58 |
| Debt / FCF | -2.53 |
| Interest Coverage | 1.17 |
Financial Efficiency
Return on equity (ROE) is 3.57% and return on invested capital (ROIC) is 2.89%.
| Return on Equity (ROE) | 3.57% |
| Return on Assets (ROA) | 2.06% |
| Return on Invested Capital (ROIC) | 2.89% |
| Return on Capital Employed (ROCE) | 5.15% |
| Revenue Per Employee | 9.49M |
| Profits Per Employee | 108,192 |
| Employee Count | 26 |
| Asset Turnover | 1.43 |
| Inventory Turnover | 2.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.57% in the last 52 weeks. The beta is 0.48, so CPH:SMSMED's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -29.57% |
| 50-Day Moving Average | 4.55 |
| 200-Day Moving Average | 5.61 |
| Relative Strength Index (RSI) | 56.69 |
| Average Volume (20 Days) | 39,244 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CPH:SMSMED had revenue of DKK 246.87 million and earned 2.81 million in profits. Earnings per share was 0.10.
| Revenue | 246.87M |
| Gross Profit | 35.25M |
| Operating Income | 5.72M |
| Pretax Income | 3.78M |
| Net Income | 2.81M |
| EBITDA | 13.58M |
| EBIT | 5.72M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 48.58M |
| Net Cash | -48.58M |
| Net Cash Per Share | -1.75 |
| Equity (Book Value) | 80.39M |
| Book Value Per Share | 2.90 |
| Working Capital | 52.82M |
Cash Flow
In the last 12 months, operating cash flow was 6.26 million and capital expenditures -25.48 million, giving a free cash flow of -19.22 million.
| Operating Cash Flow | 6.26M |
| Capital Expenditures | -25.48M |
| Free Cash Flow | -19.22M |
| FCF Per Share | -0.69 |
Margins
Gross margin is 14.28%, with operating and profit margins of 2.32% and 1.14%.
| Gross Margin | 14.28% |
| Operating Margin | 2.32% |
| Pretax Margin | 1.53% |
| Profit Margin | 1.14% |
| EBITDA Margin | 5.50% |
| EBIT Margin | 2.32% |
| FCF Margin | n/a |
Dividends & Yields
CPH:SMSMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.57% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.06% |
| FCF Yield | -14.08% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPH:SMSMED has an Altman Z-Score of 3.43.
| Altman Z-Score | 3.43 |
| Piotroski F-Score | n/a |